The study of the relationships between pre-cancer and cancer and identification of early driver mutations is becoming increasingly important as the value of molecular markers of early disease and personalised drug targets is recognised, especially now the extent of clonal heterogeneity in fully invasive disease is being realised. It has been assumed that pre-cancerous lesions exhibit a fairly passive progression to invasive disease; the degree to which they too are heterogeneous is unknown.
Introduction
Genomic changes occurring consistently in tumours provide the opportunity to develop disease markers for diagnosis, prognosis and prediction of treatment response, and targets for drug treatment.
The international efforts to catalogue genomic changes in tumours [1] are testament to the near universal acceptance of this prospect. Identifying which changes occur early in development has always been recognised as of value, increasingly so now that the genomic heterogeneity of fully invasive tumours is being revealed [2] [3] [4] [5] .
Carcinomas (especially those with squamous cell histology) often have a recognised pre-cancerous stage, epithelial dysplasia. This provides an opportunity for direct identification of the earliest genomic changes, although the genomes of pre-cancerous lesions receive little attention, most probably due to their small size and the difficulty of obtaining tissue. However, oral cancer is an excellent source of pre-cancerous lesions because its associated dysplasia can be manifest in macroscopically visible lesions including erythroplakia and leukoplakia and is almost always present adjacent to fullymalignant carcinoma within the field of tumour resection. This has enabled several studies to compare the genomes of unrelated pre-invasive lesions and carcinomas [6, 7] , as well as a few comparing lesions from the same patients [8] [9] [10] . Copy number aberrations (CNAs) and microsatellite loci have been linked with early disease and progression.. An additional feature of oral cancer is that the disease is often multifocal. Clinical presentation of lesions can be both synchronously and metachronously and lesions are frequently clonally related [11] . In the present study we took advantage of this to examine five patients with between 11 and 22 samples each. Rather than examine candidate genes, we used high-throughput sequencing to produce an unbiased catalogue of genomic changes for each patient, enabling those changes occurring at a pre-invasive stage, representing the earliest events, to be clearly identified.
An immediate outcome of our analysis was that the distribution of mutations between the various lesions was unpredictable, indicating that many sub-clones co-existed even at the earliest stages of disease. By identifying classes of co-occurring mutations within each patient's group of lesions, we were able to chart the chronology of genomic changes and from this the natural history of each patient's disease.
Materials and methods

Samples
Patients were recruited from the Oral and Maxillofacial Surgery Outpatients' clinic of Leeds General Infirmary and informed consent obtained (ethics REC ref no 07/Q1206/30 and 08/H1306/127). Fresh frozen samples and blood were collected in clinic or from the operating theatre. Formalin-fixed, paraffin-embedded (FFPE) blocks were retrieved from the hospital archives. Following sectioning and dissection where appropriate, DNA was prepared using commercial kits (Qiagen, City, State/Province, Country).
Selection of mutations for analysis
Mutations were selected for each patient based on whole genome (fresh samples) and exome (FFPE samples) sequencing from between three and five samples per patient. Where more than 8µg DNA was available, sequencing was carried out by Complete Genomics and analysed using their proprietary pipeline [12] . For samples with less than 8µg DNA, whole genomes were sequenced using an Illumina HiSeq 2000, to 30X coverage. Reads were aligned to the human genome (hg19) using BWA 0.5.9 [13] , processed using the GATK pipeline 1.3.8 [14] , and mutations called using SNVmix2 0.11.8 [15, 16] . Exome capture of FFPE samples and matching blood was performed using the Sureselect Human All Exome kit (Agilent). An average of 50X coverage was obtained using an Illumina HiSeq2500. Reads were aligned to the human genome, processed using GATK, and mutations called using Varscan2 2.3.5 [17] in somatic mode under default parameters. Due to the mix of sequencing platforms used, these results were only used to nominate mutations for further analysis, and were not used to compare samples directly.
Haloplex custom capture kits (Agilent) were designed to capture the nominated mutations for validation and direct comparison between patients. 10,000 putative somatic variants per patient were chosen for validation and clonal analysis. The selection was enriched for genes and spanned a range of mutant allele frequencies. Additionally, the potential effects of mutations were assessed using the Variant Effect Predictor [18] and Chasm 3.0 [19] . PCR primers for the 30 variants per patient deemed to have the most likely carcinogenic properties were designed using Primer3 2.2.3 [20] to increase the chances that the most informative mutations would be sequenced at high depth.
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Deep sequencing of selected variants:
Libraries were prepared from the Haloplex kits for all samples and sequenced on an Illumina HiSeq 2500 to an average of 600X coverage. The PCR-captured variants were sequenced on an Illumina MiSeq to at least 3000X coverage. All reads were aligned to the human genome, processed using GATK, and mutations called using Varscan2 in somatic mode under default parameters.
Only variants that were completely absent in the normal blood sample, had a depth of at least 50X in all samples and which were on the original list used for Haloplex/PCR design were considered for clonal analysis. These mutations had, therefore, all been called by one sequencing method and then validated by another method in at least two samples. This ensured that no results were based on de novo mutation calls, minimising the chance of results being biased by any FFPE damage, or other sequencing or mutation-calling artefact.
Low coverage copy number sequencing and viral detection
Copy number data was obtained from all samples using previously published protocols [21] . DNA was sequenced on an Illumina HiSeq 2500 to around 0.15X coverage, and aligned to the human genome using BWA. Copy number data was produced using CNAnorm 1.3.5 [22] under default parameters with manual correction to allow for heterogeneous regions of copy number change, using a control sample generated by pooling reads from 20 British Caucasian individuals from the 1000 Genomes Project [23] . Breakpoints were called using DNAcopy 1.36.0 [24] .
The same sequence data was also aligned to all known viral sequences to detect any Human Papillomavirus (HPV) infection [25] .
Clonal reconstruction (see also supplementary information online)
Mutations were assigned to classes, and clonal relationships assigned, using methods similar to those in Newburger et al. [26] , based on patterns of co-occurrence. The presence or absence of each mutation or copy number breakpoint across all samples was noted and combined to form a text string, e,g. 11011 or 01101 for two mutations across five samples. The strings for all events were compared, and identical strings grouped together to form classes. These classes represented detectable subclones. Classes supported by only one point mutation were discarded because of the increased chance of error due to miscalling, unless that point mutation was captured both by haloplex and PCR. This article is protected by copyright. All rights reserved
The cellular frequencies of copy number events were estimated for each sample using CNAnorm.
Cellular frequencies of point mutations were estimated using PyClone 0.12.7 [27] taking into account epithelial cell content, overall ploidy and local copy number. Co-occurring classes were examined to ascertain if any two classes were present in over 50% of cells in a sample. This would indicate, by the pigeonholing principle, that there must be some cells containing both classes, therefore, the classes must be part of the same sequential lineage.
Each sample had a large number (14-89) of private mutations, only found in that sample and mostly at low frequencies. These were not considered for clonal analysis and had a higher chance of being spurious because they were not validated in more than one sample.
Results
Sequencing summary (see also supplementary information online)
We examined the clonal relationships between samples for five patients. Detailed clinical and sample information for each patient is given in the supplement, along with sequencing metrics for each sample. C.G > T.A mismatch rates, a known proxy for FFPE damage [28] , were measured and found to vary very little between fresh and fixed samples. Between 837 and 2039 putative somatic mutations were validated out of 10000 in at least one sample per patient. Between 544 and 1258 of these were re-sequenced in enough depth (>50X) in all samples to be considered for clonal analysis, together with copy number data. Between 17 and 32 classes of somatic events were segregated according to patterns of co-occurrence (Table 1) . Lists of point mutations, CNAs and classes for the five patients denoted as PG008, PG055, PG030, PG136 and PG019 are shown respectively in Supplementary Tables S6 and S7; S8 and S9; S10 and S11; S12 and S13; and S14. was absent in the dysplasia furthest from the left lesion, but ubiquitous on the left. Both were present throughout the right-sided carcinoma and metastases, indicating mixed populations. The fact that this mixing was replicated in the metastases indicates that the metastatic event involved a population of cells, rather than just one founder. As every right-sided invasive sample contained both sub-clones, it is possible that they depended on each other in some way, cooperating to maintain the invasive phenotype. It is unclear if class 7, only found in invasive samples, arose in cells with class 3, 4 or 5 mutations, or represented a mixture of sub-clones descended from a combination of them. It was never found with only one of its potential ancestors (which were themselves not always found together), suggesting that one sub-clone alone was not enough to maintain invasion. Every left-sided sample contained class 6, which was only found in one dysplasia sample on the right side.
Patient PG136 (Figure 4 ) had a right lateral tongue lesion with nodal metastases. Unusually, this patient had no history of alcohol or tobacco use, or evidence of viral infection. Very few point mutations were present at high cellular frequencies, and none were shared between samples. Only copy number data is presented here. Some common events were found in adjacent normal tissue, while not appearing in all dysplasia samples, suggesting that the histological definition of normal did not always match the genomic profile. Most samples contained events at both clonal and sub-clonal cellular frequencies, indicating considerable heterogeneity, with clonal events in some samples appearing to be sub-clonal in others. There did however appear to be a dominant population at high cellular frequencies in all the SCC samples, appearing at class 5. The only homogenous samples were the biopsy, whose small size may have reduced the diversity sampled, and the metastases, indicating that only some of the multiple sub-clones detected had been able to successfully and PG136 showed overlap in the genomic profiles of some normal and some dysplasia samples, hinting that histologically normal cells may have harboured dysplastic mutations. PG019 normal samples all contained the major sub-clone detected in their adjacent dysplasia. Only two low-grade dysplasia samples were collected, and they both contained mutations that were absent from nearby high-grade dysplasia samples but were however found in carcinoma, suggesting that histological grade and genomic profiles did not closely correlate.
Progression from dysplasia to carcinoma
The carcinoma samples from PG008 and PG055 both showed a clear monoclonal origin, which was detectable in a small population of cells in one dysplasia sample, and was itself descended from the common ancestor of all the dysplasia samples. PG136 was too heterogeneous to confidently predict the origin of the invasive clone. Most PG019 carcinomas were indistinguishable from their associated 
Metastasis
This article is protected by copyright. All rights reserved Two patients presented with metastases. The PG030 primary carcinoma exhibited a mixed population of at least two distinct sub-clones. This heterogeneity was maintained in the metastases, suggesting a population of cells metastasising. The PG136 primary lesion was even more heterogeneous, but the metastases showed a clear monoclonal origin. This could imply selection of a metastatic clone, or it is also possible that the heterogeneity in PG030 was a result of clonal cooperation, and was thus necessary to found a metastasis, whereas the PG136 heterogeneity was possibly merely a product of constant accumulation of passenger events and was not necessary to maintain.
Discussion
This study has revealed in unprecedented detail the clonal relationships between pre-cancer and cancer from the same patients, charting the chronological order of genomic changes as lesions developed.
It has been generally believed that the relationship between dysplasia and carcinoma is a relatively simple one, and that in comparison with the carcinoma, the dysplasia is fairly passive, with mutations gradually accumulating until some of the cells become invasive. Our results expose the scale of variety and the complexity of relationships between dysplasia and invasive oral carcinoma. One patient (PG008) displayed classical progression, with gradual accumulation of mutations leading to invasion, whereas other patients showed considerable sub-clonal heterogeneity within the dysplasia itself, with dysplastic sub-clones independently acquiring mutations in several oncogenes without becoming invasive. PG019 and PG030 showed evidence of dysplastic cells leaving the primary tumour and seeding fresh lesions and of mutationally-similar cells having invasive or non-invasive phenotype depending on their surroundings. PG030 also showed potential cooperation between subclones to maintain a lesion.
Study design
When studying the relationship between dysplasias and carcinoma, the usual method is to examine groups of both types of sample [6, 7] . The number of studies of dysplasia and carcinoma in the same patient are very few. They tend to examine candidates such as TP53 or microsatellites and use limited sample numbers, so the full extent to which different morphological grades, or different regions of the same lesion are similar or different is not fully exposed [8, 9] .
By combining point mutation and CNA data, and using multiple samples per patient, we have been able not only to show the relationships between different cell populations within and between lesions, but also to associate tumour progression in each patient with specific genomic changes and infer the processes by which each lesion was initiated, developed and then spread.
We chose to use the recently described method [3] [4] [5] whereby initial sequencing results are used to nominate a selected group of mutations for much deeper sequencing. Our clonal relationships were entirely derived from the capture and CNA results, with no further input from our initial sequencing experiments. There have been a number of informatics approaches published [27, 29, 30 ] to infer subclonal architecture in tumour samples. These cluster mutations using accurately measured cellular frequencies. However, in common with another recent study [26] , we found that our mutations did always split into multiple distinct clusters. As for that project and one other [2] , we had the advantage of working with large numbers of samples per patient. Therefore we were able to adopt a similar approach and classify mutations by patterns of co-occurrence, relying on direct observations of mutation presence or absence, rather than inferring relationships from cellular frequencies which are themselves inferred.
TP53
We have listed all the mutations validated in our samples (Supplementary Tables S6, S8 , S10, S12, S14). Some genes were mutated in more than one patient, but not in an early clone shared between many samples. The only gene that was frequently mutated at an early stage of development was
TP53.
It has long been suspected that the TP53 gene is important in head and neck SCC, and that it is often mutated in dysplasia as well as carcinoma [31] [32] [33] . This was confirmed by a recent exome sequencing study, which showed that TP53 was by far the most commonly mutated gene and that P53 inactivation, either by mutation or HPV infection, was almost universal for this disease [34] . Our results reiterate that finding, and confirm that where present (by mutation in three patients and with HPV infection in one), it was always amongst the earliest changes detected. In PG019, a second subsequent TP53 mutation coincided with more aggressive disease, making it likely that in conbination the two mutations totally ablated P53 protein.
The natural history of head and neck SCC The frequent observation of the close physical association of dysplasia and carcinoma in head and neck SCC is generally believed to be indicative of a sequential developmental relationship [35] [36] [37] [38] .
In this study, the dysplasia samples all shared a common ancestor with the nearby SCC, but were not necessarily directly ancestral to it. The SCC samples were usually descended from a minor sub-clone from within one of the dysplasia samples. In the case of PG030 and PG019, SCC samples were descended from a relatively distant dysplasia sample, rather than the adjacent one.
All patients exhibited some level of dysplastic heterogeneity, which was particularly pronounced in patients PG055 and PG136. These samples showed evidence that the dysplasias developed considerable clonal variation before the invasive clone emerged, and have possibly continued to evolve since [39] .
Many different pathways capable of generating HNSCC have been proposed, and associated with tobacco, alcohol use and viral infection [34, [40] [41] [42] . Our five patients all developed their histologically similar tumours in different ways. PG136 appeared almost devoid of point mutations, so it is not known how the disease was triggered. PG055 was fuelled by viral infection. PG008 either had a very inactive, or short pre-cancerous phase, with most mutations occurring from either shortly before invasion, or afterwards.
Both lesions from PG030 were mixed populations, with all samples containing multiple sub-clones, leading to the possibility that they depended on each other to maintain an invasive phenotype, as has recently been described in breast cancer [43] . The left lesion was seeded by a pre-cancerous subclone from the right lesion. PG019 showed a slow disease progression, with gradual increase in aggressiveness as mutations accumulated, and eventual spread of mutated cells throughout the oral cavity.
Patterns of tumour evolution
Six possible different patterns of tumour initiation and progression have been inferred from our observations. These processes are summarised in Figure 6 . Most patients exhibited more than one of This article is protected by copyright. All rights reserved these processes as their disease spread to a different part of the oral cavity or metastasised. These only represent the patterns inferred from these five patients, rather than any general rule. The fact that six patterns were inferred from only five patients suggests that applying any general rules to HNSCC development is a very simplistic approach.
The simplest process is characterised by local initiation and progression ( Figure 6A ). Initial mutations in normal tissue give rise to dysplasia containing one or more sub-clones. In one of these sub-clones, further mutations give rise to an invasive clone. This was observed in PG008, PG055 and PG136.
Slightly more complex is the possibility of cooperating sub-clones ( Figure 6B ). PG030 invasive samples all contained multiple sub-clones that were also seen in non-invasive samples, sometimes in a majority of cells. It is possible that the sub-clones depend on each other to maintain an invasive phenotype. New SCCs were also seeded by distant dysplasias ( Figure 6C ) either spreading through the epithelium [11] or by detaching and alighting in the new position [44] . Figure   6D ).
Two types of nodal metastasis were seen. In PG030, the sub-clonal variation of the primary tumour was maintained in the metastases ( Figure 6E ), whereas in PG136, a heterogeneous primary tumour gave rise to a single metastatic clone ( Figure 6F ).
Conclusions
The work described here exposes the diversity of processes by which histologically similar tumours are initiated, develop and spread, and the hitherto unknown complexity in the relationships between pre-invasive and invasive disease. We show that dysplasia has considerable sub-clonal variation, and that a carcinoma is often descended from a minority sub-clone in just part of that dysplasia. 
